As viral vaccines are increasingly used to meet global health needs, the pharmaceutical industry is manufacturing larger amounts of virus to make them. A new method of virus detection from researchers at Carnegie Mellon University's Department of Chemical Engineering is poised to improve quality control in vaccine manufacturing by rapidly quantifying viral genomes in samples taken directly from bioreactors.